FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Taichi Azuma

Research Profile

Chemicals & Drugs

Procedures

Anatomy

Disorders

Physiology

Living Beings

Human Herpesvirus 6

Co-author Network

Publications

TOP 3
Jun Yamanouchi; Taichi Azuma; Hitoshi Hasegawa; Takaaki Hato; Shinji Kobayashi; Kazuhiro Miyoshi; Masaki Yasukawa
[Rituximab for managing refractory thrombotic thrombocytopenic purpura: a report of three cases].
Hisaharu Shikata; Atsuro Sugita; Yoshihiro Yakushijin; Jun Yamanouchi; Taichi Azuma; Takaaki Hato; Natsuki Matsushita; Naoya Nakamura; Akira Sakai; Masaki Yasukawa
Role of activation-induced cytidine deaminase in the progression of follicular lymphoma.
Jun Yamanouchi; Taichi Azuma; Takaaki Hato; Kazuhiro Miyoshi; Toshiyuki Niiya; Ikuya Sakai; Masaki Yasukawa
A new four-way variant t(5;17;15;20)(q33;q12;q22;q11.2) in acute promyelocytic leukemia.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Taichi Azuma (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Jun Yamanouchi; Taichi Azuma; Hitoshi Hasegawa; Takaaki Hato; Shinji Kobayashi; Kazuhiro Miyoshi; Masaki Yasukawa
[Rituximab for managing refractory thrombotic thrombocytopenic purpura: a report of three cases].
[Rinshō ketsueki] The Japanese journal of clinical hematology 2013;54(2):205-9.
2012: Hisaharu Shikata; Atsuro Sugita; Yoshihiro Yakushijin; Jun Yamanouchi; Taichi Azuma; Takaaki Hato; Natsuki Matsushita; Naoya Nakamura; Akira Sakai; Masaki Yasukawa
Role of activation-induced cytidine deaminase in the progression of follicular lymphoma.
Cancer science 2012;103(3):415-21.
2011: Jun Yamanouchi; Taichi Azuma; Takaaki Hato; Kazuhiro Miyoshi; Toshiyuki Niiya; Ikuya Sakai; Masaki Yasukawa
A new four-way variant t(5;17;15;20)(q33;q12;q22;q11.2) in acute promyelocytic leukemia.
International journal of hematology 2011;94(4):395-8.
2011: Yoshihiro Yakushijin; Hisaharu Shikata; Ikue Takaoka; Tamami Horikawa; Kazuhito Takeuchi; Jun Yamanouchi; Taichi Azuma; Hiroshi Narumi; Takaaki Hato; Masaki Yasukawa
Usage of granulocyte colony-stimulating factor every 2 days is clinically useful and cost-effective for febrile neutropenia during early courses of chemotherapy.
International journal of clinical oncology 2011;16(2):118-24.
2011: Jun An; Hiroshi Fujiwara; Koichiro Suemori; Toshiyuki Niiya; Taichi Azuma; Kazushi Tanimoto; Toshiki Ochi; Yoshiki Akatsuka; Junichi Mineno; Hidetoshi Ozawa; Fumihiko Ishikawa; Kiyotaka Kuzushima; Masaki Yasukawa
Activation of T-cell receptor signaling in peripheral T-cell lymphoma cells plays an important role in the development of lymphoma-associated hemophagocytosis.
International journal of hematology 2011;93(2):176-85.
2010: Taichi Azuma; Jun Yamanouchi; Katsuji Inoue; Masashi Kohno; Hiroshi Narumi; Hiroshi Fujiwara; Yoshihiro Yakushijin; Takaaki Hato; Masaki Yasukawa
Derivative (1;18)(q10;q10) in essential thrombocythemia.
Cancer genetics and cytogenetics 2010;199(1):62-4.
2009: Jun Yamanouchi; Tamami Abe; Taichi Azuma; Hiroshi Narumi; Hiroshi Fujiwara; Yoshihiro Yakushijin; Takaaki Hato; Masaki Yasukawa
[Acquired hemophilia complicated with multiple muscle abscess by Nocardia].
[Rinshō ketsueki] The Japanese journal of clinical hematology 2009;50(6):495-8.
2009: Yuichi Murakami; Jun Yamanouchi; Taichi Azuma; Yuichi Ikeda; Hiroshi Narumi; Hiroshi Fujiwara; Yoshihiro Yakushijin; Takaaki Hato; Masaki Yasukawa
[Primary osseous lymphoma with pathological fracture during therapy].
[Rinshō ketsueki] The Japanese journal of clinical hematology 2009;50(3):187-91.
2009: Toshiki Ochi; Taichi Azuma; Kiyonori Takada; Hiroshi Fujiwara; Hiroki Teraoka; Yoko Ueda; Yoshihiro Yakushijin; Takaaki Hato; Hitoshi Hasegawa; Masaki Yasukawa
Germ cell tumor concomitant with acquired immune deficiency syndrome.
Internal medicine (Tokyo, Japan) 2009;48(24):2129-32.
2009: Toshiki Ochi; Hiroshi Fujiwara; Koichiro Suemori; Taichi Azuma; Yoshihiro Yakushijin; Takaaki Hato; Kiyotaka Kuzushima; Masaki Yasukawa
Aurora-A kinase: a novel target of cellular immunotherapy for leukemia.
Blood 2009;113(1):66-74.
2008: Koichiro Suemori; Hiroshi Fujiwara; Toshiki Ochi; Taichi Azuma; Jun Yamanouchi; Hiroshi Narumi; Yoshihiro Yakushijin; Takaaki Hato; Hitoshi Hasegawa; Masaki Yasukawa
Identification of an epitope derived from CML66, a novel tumor-associated antigen expressed broadly in human leukemia, recognized by human leukocyte antigen-A*2402-restricted cytotoxic T lymphocytes.
Cancer science 2008;99(7):1414-9.
2007: Ai Fujiwara; Taichi Azuma; Jun Yamanouchi; Hiroshi Narumi; Yoshihiro Yakushijin; Masaki Yasukawa; Takaaki Hato; Naohiko Hamaguchi; Toru Kadowaki; Hironobu Hamada
[Intravascular large B-cell lymphoma presenting as interstitial lung disease].
Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 2007;96(12):2783-5.
2006: Taichi Azuma; Emi Ozaki; Yoshihiro Yakushijin; Masashi Kohno; Ikuya Sakai; Kiyonori Takada
[Esophageal stricture following complete remission after chemotherapy for malignant lymphoma in an elderly patient].
Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics 2006;43(4):531-5.
2006: Hironari Niiya; Jin Lei; Yun Guo; Taichi Azuma; Yoshihiro Yakushijin; Ikuya Sakai; Takaaki Hato; Masaya Tohyama; Koji Hashimoto; Masaki Yasukawa
Human herpesvirus 6 impairs differentiation of monocytes to dendritic cells.
Experimental hematology 2006;34(5):642-53.
2005: Taichi Azuma; Ikuya Sakai; Takuya Matsumoto; Akira Ozawa; Nozomu Tanji; Akito Watanabe; Naoyuki Uchida; Hiroshi Narumi; Yoshihiro Yakushijin; Takaaki Hato; Masaki Yasukawa; Shigeru Fujita
Leukemoid reaction in association with bone marrow necrosis due to metastatic prostate cancer.
Internal medicine (Tokyo, Japan) 2005;44(10):1093-6.
2005: Yun Guo; Hironari Niiya; Taichi Azuma; Naoyuki Uchida; Yoshihiro Yakushijin; Ikuya Sakai; Takaaki Hato; Masuhiro Takahashi; Satoru Senju; Yasuharu Nishimura; Masaki Yasukawa
Direct recognition and lysis of leukemia cells by WT1-specific CD4+ T lymphocytes in an HLA class II-restricted manner.
Blood 2005;106(4):1415-8.
2005: Hironari Niiya; Ikuya Sakai; Jin Lei; Taichi Azuma; Naoyuki Uchida; Yoshihiro Yakushijin; Takaaki Hato; Shigeru Fujita; Masaki Yasukawa
Differential regulation of perforin expression in human CD4+ and CD8+ cytotoxic T lymphocytes.
Experimental hematology 2005;33(7):811-8.
2004: Taichi Azuma; Takemi Otsuki; Kiyotaka Kuzushima; Christopher J Froelich; Shigeru Fujita; Masaki Yasukawa
Myeloma cells are highly sensitive to the granule exocytosis pathway mediated by WT1-specific cytotoxic T lymphocytes.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(21):7402-12.
2004: Hironari Niiya; Taichi Azuma; Lei Jin; Naoyuki Uchida; Atsushi Inoue; Hitoshi Hasegawa; Shigeru Fujita; Masaya Tohyama; Koji Hashimoto; Masaki Yasukawa
Transcriptional downregulation of DC-SIGN in human herpesvirus 6-infected dendritic cells.
The Journal of general virology 2004;85(Pt 9):2639-42.
2004: K Kojima; Ikuya Sakai; A Hasegawa; Hironari Niiya; Taichi Azuma; Y Matsuo; N Fujii; Mitsune Tanimoto; Shigeru Fujita
FLJ10849, a septin family gene, fuses MLL in a novel leukemia cell line CNLBC1 derived from chronic neutrophilic leukemia in transformation with t(4;11)(q21;q23).
Leukemia 2004;18(5):998-1005.
2004: Hiroshi Narumi; K Kojima; Y Matsuo; H Shikata; K Sekiya; Toshiyuki Niiya; Shiro Bando; Hironari Niiya; Taichi Azuma; Yoshihiro Yakushijin; Ikuya Sakai; Masaki Yasukawa; Shigeru Fujita
T-cell large granular lymphocytic leukemia occurring after autologous peripheral blood stem cell transplantation.
Bone marrow transplantation 2004;33(1):99-101.
2002: M Makita; Taichi Azuma; H Hamaguchi; Hironari Niiya; K Kojima; Shigeru Fujita; Mitsune Tanimoto; M Harada; Masaki Yasukawa
Leukemia-associated fusion proteins, dek-can and bcr-abl, represent immunogenic HLA-DR-restricted epitopes recognized by fusion peptide-specific CD4+ T lymphocytes.
Leukemia 2002;16(12):2400-7.
2002: Masaki Yasukawa; Hayato Yamauchi; Taichi Azuma; Kiyonori Takada; Mina Ishimura; Shigeru Fujita
Dramatic efficacy of fludarabine in the treatment of an aggressive case of splenic lymphoma with villous lymphocytes.
European journal of haematology 2002;69(2):112-4.
2002: Masanori Makita; Akio Hiraki; Taichi Azuma; Akihiro Tsuboi; Yoshihiro Oka; Haruo Sugiyama; Shigeru Fujita; Mitsune Tanimoto; Mine Harada; Masaki Yasukawa
Antilung cancer effect of WT1-specific cytotoxic T lymphocytes.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(8):2626-31.
2002: Taichi Azuma; Masanori Makita; Kanji Ninomiya; Shigeru Fujita; Mine Harada; Masaki Yasukawa
Identification of a novel WT1-derived peptide which induces human leucocyte antigen-A24-restricted anti-leukaemia cytotoxic T lymphocytes.
British journal of haematology 2002;116(3):601-3.